Higher Prevalence of TDP-43 Proteinopathy in Cognitively Normal Asians: A Clinicopathological Study on a Multiethnic Sample
Carregando...
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Citação
BRAIN PATHOLOGY, v.26, n.2, p.177-185, 2016
Resumo
Transactive response DNA binding protein 43 (TDP-43) proteinopathy is the major hallmark of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. It is also present in a subset of Alzheimer's disease cases. Recently, few reports showed TDP-43 changes in cognitively normal elderly. In Caucasians, TDP-43 proteinopathy independently correlate with cognitive decline. However, it is challenging to establish direct links between cognitive and/or neuropsychiatric symptoms and protein inclusions in neurodegenerative diseases because individual cognitive reserves modify the threshold for clinical disease expression. Cognitive reserve is influenced by demographic, environmental and genetic factors. We investigated the relationships between demographic, clinical and neuropathological variables and TDP-43 proteinopathy in a large multiethnic sample of cognitively normal elderly. TDP-43 proteinopathy was identified in 10.5%, independently associated with older age (P=0.03) and Asian ethnicity (P=0.002). Asians showed a higher prevalence of TDP-43 proteinopathy than Caucasians, even after adjustment for sex, age, Braak stage and schooling (odds ratio=3.50, confidence interval 1.41-8.69, P=0.007). These findings suggested that Asian older adults may be protected from the clinical manifestation of brain TDP-43 proteinopathy. Future studies are needed to identify possible race-related protective factors against clinical expression of TDP-43 proteinopathies.
Palavras-chave
Asian, autopsy, cognitively normal elderly, dementia, postmortem, race, TDP-43 proteinopathy
Referências
- Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48
- Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2
- Grinberg LT, 2013, CLINICS, V68, P1140, DOI 10.6061/clinics/2013(08)13
- Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182
- McKeith IG, 1996, NEUROLOGY, V47, P1113
- Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937
- Probst A, 2007, ACTA NEUROPATHOL, V114, P335, DOI 10.1007/s00401-007-0262-1
- Andrade-Moraes CH, 2013, BRAIN, V136, P3738, DOI 10.1093/brain/awt273
- Adler CH, 2010, MOVEMENT DISORD, V25, P642, DOI 10.1002/mds.22971
- BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138
- McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307
- Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137
- Hu WT, 2008, ACTA NEUROPATHOL, V116, P215, DOI 10.1007/s00401-008-0400-4
- Klos KJ, 2006, NEUROLOGY, V66, P1100, DOI 10.1212/01.wnl.0000204179.88955.fa
- Farfel JM, 2013, NEUROLOGY, V81, P650, DOI 10.1212/WNL.0b013e3182a08f1b
- Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y
- Froehlich TE, 2001, J AM GERIATR SOC, V49, P477
- MORRIS JC, 1993, NEUROLOGY, V43, P2412
- Meguro K, 2001, INT J GERIATR PSYCH, V16, P775, DOI 10.1002/gps.430.abs
- Uchino A, 2014, BRAIN PATHOL, V24, P65
- Miles TP, 2001, J AM GERIATR SOC, V49, P490, DOI 10.1046/j.1532-5415.2001.49098.x
- Nag S, 2015, ANN NEUROL, V77, P942, DOI 10.1002/ana.24388
- Arnold SJ, 2013, ACTA NEUROPATHOL, V126, P51, DOI 10.1007/s00401-013-1110-0
- Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z
- Nelson PT, 2014, ACTA NEUROPATHOL, V127, P825, DOI 10.1007/s00401-014-1282-2
- JORM AF, 1994, PSYCHOL MED, V24, P145
- Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1
- Geser F, 2010, ARCH NEUROL-CHICAGO, V67, P1238, DOI 10.1001/archneurol.2010.254
- Caselli RJ, 2010, NEUROSCI LETT, V473, P168, DOI 10.1016/j.neulet.2010.02.016
- DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U
- Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0
- Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2
- Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154
- CUMMINGS JL, 1994, NEUROLOGY, V44, P2308
- Geser F, 2009, ARCH NEUROL-CHICAGO, V66, P180, DOI 10.1001/archneurol.2008.558
- Ikejima C, 2009, STROKE, V40, P2709, DOI 10.1161/STROKEAHA.108.542308
- Cronin S, 2007, NEUROLOGY, V68, P1002, DOI 10.1212/01.wnl.0000258551.96893.6f
- MORRIS JC, 1993, NEUROLOGY, V43, P2457
- Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P229, DOI 10.1097/WAD.0b013e318199d833
- Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3
- Josephs KA, 2008, NEUROBIOL AGING, V29, P566, DOI 10.1016/j.neurobiolaging.2006.10.032
- Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147
- Stefanits H, 2012, ACTA NEUROPATHOL, V123, P449, DOI 10.1007/s00401-011-0936-6
- Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
- Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9
- Rauramaa T, 2013, J NEUROPATH EXP NEUR, V72, P452, DOI 10.1097/NEN.0b013e318292492a
- Buratti E, 2010, RNA BIOL, V7, P420
- Bennett DA, 2003, NEUROLOGY, V60, P1909
- Waite L, 1999, ALZ DIS ASSOC DIS, V13, P34, DOI 10.1097/00002093-199903000-00005
- Schlesinger D, 2013, MOL PSYCHIATR, V18, P79, DOI 10.1038/mp.2011.136
- BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239
- Cardoso M A, 1997, J Epidemiol, V7, P198
- Cummings JL, 1997, NEUROLOGY, V48, pS10
- Cummings Jeffrey L, 2005, Rev Neurol Dis, V2, P80
- Ferretti REL, 2010, DEMENT NEUROPSYCHOL, V4, P138
- Grinberg Lea Tenenholz, 2011, Front Neurol, V2, P42, DOI 10.3389/fneur.2011.00042
- IBGE, 2010, EST PESQ INF DEM SOC
- King A, 2015, J NEURAL TRANSM, V122, P1499, DOI 10.1007/s00702-015-1410-8
- Lipson J G, 1996, Reflections, V22, P9
- Wilson RS, 2013, JAMA NEUROL, V70, P1418, DOI 10.1001/jamaneurol.2013.3961